Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Thermo Fisher to $620 from $670 and keeps an Overweight rating on the shares after updating estimates for Q1 results and management commentary. The firm’s adjusted EPS estimates in Q2 and FY23 are now $5.36 and $23.71, respectively, from $5.60 and $23.74 prior to the report.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher price target lowered to $670 from $693 at Baird
- Thermo Fisher price target lowered to $610 from $625 at Barclays
- Thermo Fisher Scientific Earnings Update: Did it Beat Estimate Forecasts?
- Thermo Fisher backs FY23 adjusted EPS view $23.70, consensus $23.71
- Thermo Fisher Slides on Weak Q1